Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial

被引：0
|
作者：
Schreiber, S. [1 ]
Feagan, B. [2 ,3 ]
Peyrin-Biroulet, L. [4 ]
Vermeire, S. [5 ]
Faes, M. [6 ]
Harris, K. [7 ]
Oortwijn, A. [7 ]
Daniele, P. [8 ]
Patel, H. [6 ]
Danese, S. [9 ,10 ]
机构：
[1] Univ Kiel, Dept Gen Internal Med, Kiel, Germany
[2] Alimentiv Inc, London, ON, Canada
[3] Western Western Univ, London Hlth Sci Ctr, Div Gastroenterol, London, ON, Canada
[4] Univ Lorraine, Univ Hosp Nancy, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[5] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[6] Galapagos Nv, Mechelen, Belgium
[7] Galapagos Nv, Leiden, Netherlands
[8] Cytel Hlth, Toronto, ON, Canada
[9] Univ Vita Salute, San Raffaele, Milan, Italy
[10] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
INFLAMMATORY-BOWEL-DISEASE;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP07
引用
收藏
页码：I007 / I008
页数：3
相关论文
共 50 条
  • [31] CLINICAL, ENDOSCOPIC, AND HISTOLOGIC ACTIVITY PREDICT HEALTH RELATED QUALITY OF LIFE FOR PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS TREATED WITH MULTIMATRIX MESALAMINE
    Yarlas, A.
    Willian, M. K.
    Nag, A.
    VALUE IN HEALTH, 2017, 20 (05) : A187 - A187
  • [32] HEALTH-RELATED QUALITY OF LIFE IN ULCERATIVE COLITIS PATIENTS TREATED WITH TOFACITINIB IN RANDOMIZED CONTROLLED TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    BG, Geddamuri
    Thode, R.
    Dasari, A.
    Hyderbolni, R.
    Chidirala, S.
    Nadimpally, J.
    Kamra, S.
    Goyal, R.
    Aggarwal, A.
    VALUE IN HEALTH, 2022, 25 (12) : S405 - S406
  • [33] Rheumatic manifestations in Crohn's disease (CD) and ulcerative colitis (UC) have clinical impact on patients' health-related quality of life
    Palm, O.
    Bernklev, T.
    Moum, B.
    Gran, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 86 - 86
  • [34] The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
    Bingham, Clifton O., III
    Walker, David
    Nash, Peter
    Lee, Susan J.
    Ye, Lei
    Hu, Hao
    Khalid, Javaria Mona
    Combe, Bernard
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [35] The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
    Clifton O. Bingham
    David Walker
    Peter Nash
    Susan J. Lee
    Lei Ye
    Hao Hu
    Javaria Mona Khalid
    Bernard Combe
    Arthritis Research & Therapy, 24
  • [36] FATIGUE AND HEALTH-RELATED QUALITY OF LIFE IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH): A POST-HOC ANALYSIS OF PEGCETACOPLAN PEGASUS FACIT-FATIGUE TRIAL DATA
    Panse, J.
    Hakimi, Z.
    Wilson, K.
    Fishman, J.
    Wojciechowski, P.
    Wdowiak, M.
    Nazir, J.
    Horneff, R.
    VALUE IN HEALTH, 2022, 25 (12) : S445 - S445
  • [37] Post Hoc Health-Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies
    Thiery-Vuillemin, Antoine
    Fizazi, Karim
    Sartor, Oliver
    Oudard, Stephane
    Bury, Denise
    Ozatilgan, Ayse
    Poole, Elizabeth M.
    Eisenberger, Mario
    de Bono, Johann
    ONCOLOGIST, 2021, 26 (07): : E1179 - E1188
  • [38] Effect of adalimumab on clinical outcomes and health-related quality of life amongst patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
    Travis, S.
    Feagan, B.
    Peyrin-Biroulet, L.
    Panaccione, R.
    Danese, S.
    Lazar, A.
    Robinson, A.
    Petersson, J.
    Bereswill, M.
    Skup, M.
    Chen, N.
    Wang, S.
    Thakkar, R.
    Chao, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S391 - S392
  • [39] Long-term efficacy, safety and health-related quality of life in patients who achieved comprehensive disease control with filgotinib in SELECTION: analysis of ∼3 years in SELECTIONLTE
    Feagan, B. G.
    Matsuoka, K.
    Rogler, G.
    Laharie, D.
    Vermeire, S.
    Danese, S.
    Loftus, E. V., Jr.
    Beales, I.
    Schreiber, S.
    Kim, H. J.
    Faes, M.
    Masior, T.
    Rudolph, C.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1278 - I1279
  • [40] HEALTH-RELATED QUALITY-OF-LIFE AMONG GENOTYPE 1 TREATMENT-EXPERIENCED CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES FROM THE REALIZE STUDY
    Sherman, K.
    Muir, A.
    Aggarwal, J.
    Donepudi, M.
    Goss, T.
    Martin, M.
    Vera-Llonch, M.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S372 - S372
12345